UNSPSC 51112522: Sarcolysin

This classification denotes a nitrogen mustard compound with the molecular formula C13H18Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A960M0G5TP, chemically known as l-phenylalanine, 4-(bis(2-chloroethyl)amino)- but more generally known as sarcolysin, which bears US NIH Compound Identifier 4053. European Medicines Agency schedules Sarcolysin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10448MIG.

UNSPSC 51112522 Sarcolysin is a Commodity code representing a specific pharmaceutical active pharmaceutical ingredient (API) that state and local health agencies procure for use in medical research, clinical trials, or limited therapeutic applications where authorized. The code captures purchases of sarcolysin — a nitrogen mustard derivative — in its pharmaceutical form as a raw material or finished-dose product. State and local governments acquire sarcolysin primarily through health departments, medical research institutions, university hospital systems, and correctional health services when the drug is needed for approved investigational or clinical use. Procurement typically occurs as part of larger pharmaceutical supply contracts or through specialized medical procurement channels managed by state pharmacy programs or academic medical centers. The scope of work under this code reflects niche, highly regulated pharmaceutical sourcing rather than mainstream drug procurement.

The most recent state and local contract opportunities block contains no records for this code. The absence of visible recent solicitation activity suggests either minimal current demand among state and local buyers, limited posting of opportunities in accessible procurement databases, or procurement conducted through standing state pharmaceutical contracts and cooperative purchasing vehicles that do not appear as discrete opportunities. Buyers pursuing sarcolysin would typically source through established state health department pharmaceutical accounts, federal supply schedules, or group purchasing organizations (GPOs) rather than through competitive sealed bids or formal RFPs. Verify current demand by contacting state health department procurement offices directly and cross-referencing standing pharmaceutical supply agreements with active contracting vehicles in your target states.